#biotechnology
CAR T-Cell Therapy Market Expected to Reach USD 13.56 Billion by 2031 | MarketsandMarkets™
Rising Cancer Cases, Technological Advancements, and Expanding CAR-T Applications Continue to Drive Global Market Growth Rising Cancer Cases, Technological Advancements, and Expanding CAR-T Applications Continue to Drive Global Market Growth
Protein Expression Market worth $7.65 billion by 2031 | MarketsandMarkets™
DELRAY BEACH, Fla., May 22, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Protein Expression Market is projected to grow from about USD 5.14 billion in 2026 to USD 7.65 billion by 2031, at a CAGR of 8.3%. Browse 250 market data Tables and 50 Figur…
Protein Expression Market worth $7.65 billion by 2031 | MarketsandMarkets™
DELRAY BEACH, Fla., May 22, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Protein Expression Market is projected to grow from about USD 5.14 billion in 2026 to USD 7.65 billion by 2031, at a CAGR of 8.3%. Browse 250 market data Tables and 50 Figur…
[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Genome Editing Market size & share revenue was valued at approximately USD 11.2 Billion in 2025 and is expected to reach USD 13.1…
Dynamic metabolic modeling uncovers systems-level strategies to simultaneously maximize levan yield and substrate efficiency in Bacillus subtilis LY7.16
Author summary Biopolymers are increasingly attractive for applications in medicine and the food industry due to their non-toxic and biocompatible properties. Levan is one of holding significant promises, yet its typically low synthesis yield hinders an advan…
Global AI in Life Sciences Market Gearing Up for Outstanding Expansion at a CAGR of ~20% by 2034 | DelveInsight
The AI in life sciences market is experiencing robust expansion due to several important factors. Rising demand for accelerated drug discovery and development is prompting pharmaceutical and biotechnology companies to implement AI technologies that can shorte…
Non-Animal Alternative Testing Market Size to Reach $29.4 Billion by 2030, Globally, at 13.5% CAGR: Allied Market Research
Summary: The non-animal alternative testing market is being driven by several factors, including increasing awareness and concern over animal welfare, a growing focus on the development of non-animal testing methods, and the need for more accurate and predict…
DNA Synthesis Market to Reach $30.4 billion, Globally, by 2035 at 18.2% CAGR: Allied Market Research
The DNA synthesis market is witnessing strong adoption across pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and synthetic biology firms due to its critical role in enabling advanced genet…
Biotechnology and Pharmaceutical Services Outsourcing Analysis Report 2026: $101.56 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
The biotechnology and pharmaceutical services outsourcing market is set to capitalize on the increasing complexity of drug pipelines, demand for specialized expertise, and growth in clinical research. Opportunities lie in expanding AI-driven drug discovery, f…
Clinical Trials Market Analysis/Forecasts 2026-2034 by Phases, Indications, Study Designs, Countries and Competitive Landscape
The clinical trials market is forecasted to experience strong growth, expanding from $92.63 billion to $158.1 billion between 2025 and 2034, driven by rising pharmaceutical and biotechnology R&D, chronic disease prevalence, and demand for innovative treatment…
Biologics CDMO Research Report 2026: $48.07 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
The biologics CDMO market presents growth opportunities driven by increasing demand for cell and gene therapies, advancements in bioprocessing technologies, and the expansion of global manufacturing capacities. The rise in biosimilar pipelines and need for co…